Rituximab shows no effect on remission in patients with refractory nephrotic syndrome
نویسندگان
چکیده
منابع مشابه
Rituximab shows no effect on remission in patients with refractory nephrotic syndrome
To assess the efficacy of rituximab in treatment of refractory nephrotic syndrome (NS) compared with other agents.Studies were searched from Web of Science, PubMed, and CNKI up to April 2016. The standardized mean difference or relative risk or odds ratio and 95% confidence intervals were used to assess the efficacy of rituximab treatment compared with other agents in refractory NS.Totally, 8 s...
متن کاملSpontaneous remission of nephrotic syndrome in patients with IgA nephropathy.
BACKGROUND IgA nephropathy (IgAN) can be complicated by nephrotic syndrome. Because the spontaneous resolution of heavy proteinuria is rare, corticosteroid therapy should be considered in such cases, particularly when IgAN is combined with minimal-change disease. Here, we report our experience of spontaneous remission of nephrotic syndrome in patients with IgAN and the long-term outcomes of the...
متن کاملRepeated Administrations of Rituximab along with Steroids and Immunosuppressive Agents in Refractory Steroid-resistant Nephrotic Syndrome.
BACKGROUND A recent randomized control trial in children with steroid-resistant nephrotic syndrome revealed that two doses of rituximab did not reduce proteinuria. CASE CHARACTERISTICS A 14-month-old boy developed refractory steroid-resistant nephrotic syndrome due to focal segmental glomerulosclerosis. OBSERVATION The patient achieved complete remission 11 months after disease onset follow...
متن کاملRemission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrane sulphate adsorption.
Key words: ankylosing spondylitis; hypercholesterolae-concentrations remained dramatically high (28 mmol/l and 20 mmol/l respectively). Simvastatin was therefore mia; hypertriglyceridaemia; LDL apheresis; priapism; minimal-change nephrotic syndrome; sulphasalazine stopped. The severity of the nephrotic syndrome and the renal insuÃciency made the use of fibric acid derivatives unsafe. The use of...
متن کاملRituximab Treatment for Nephrotic Syndrome in Children
In the past 10 years, many reports have suggested that rituximab, a chimeric anti-CD20 monoclonal antibody, is effective for children with complicated, frequently relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS). However, those reports were case reports, case series, retrospective surveys, and single-arm or short-term trials. Therefore, well-designed controlled trials are required ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medicine
سال: 2016
ISSN: 0025-7974
DOI: 10.1097/md.0000000000005320